These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27077528)

  • 1. Synthesis and Pharmacology of (Pyridin-2-yl)methanol Derivatives as Novel and Selective Transient Receptor Potential Vanilloid 3 Antagonists.
    Gomtsyan A; Schmidt RG; Bayburt EK; Gfesser GA; Voight EA; Daanen JF; Schmidt DL; Cowart MD; Liu H; Altenbach RJ; Kort ME; Clapham B; Cox PB; Shrestha A; Henry R; Whittern DN; Reilly RM; Puttfarcken PS; Brederson JD; Song P; Li B; Huang SM; McDonald HA; Neelands TR; McGaraughty SP; Gauvin DM; Joshi SK; Banfor PN; Segreti JA; Shebley M; Faltynek CR; Dart MJ; Kym PR
    J Med Chem; 2016 May; 59(10):4926-47. PubMed ID: 27077528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design and synthesis of transient receptor potential vanilloid 3 inhibitors with novel skeleton.
    Lv M; Wu H; Qu Y; Wu S; Wang J; Wang C; Luan Y; Zhang Z
    Bioorg Chem; 2021 Sep; 114():105115. PubMed ID: 34175725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Inhibition of the Temperature-Sensitive and Ca
    Zhang H; Sun X; Qi H; Ma Q; Zhou Q; Wang W; Wang K
    J Pharmacol Exp Ther; 2019 Jan; 368(1):21-31. PubMed ID: 30377214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational discovery, structural optimization and biological evaluation of novel inhibitors targeting transient receptor potential vanilloid type 3 (TRPV3).
    Zhang F; Lin Y; Min W; Hou Y; Yuan K; Wang J; Yang P
    Bioorg Chem; 2021 Sep; 114():105093. PubMed ID: 34182309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermally activated TRPV3 channels.
    Luo J; Hu H
    Curr Top Membr; 2014; 74():325-64. PubMed ID: 25366242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipruritic Effect of Natural Coumarin Osthole through Selective Inhibition of Thermosensitive TRPV3 Channel in the Skin.
    Sun XY; Sun LL; Qi H; Gao Q; Wang GX; Wei NN; Wang K
    Mol Pharmacol; 2018 Oct; 94(4):1164-1173. PubMed ID: 30108138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Brown BS; Keddy R; Zheng GZ; Schmidt RG; Koenig JR; McDonald HA; Bianchi BR; Honore P; Jarvis MF; Surowy CS; Polakowski JS; Marsh KC; Faltynek CR; Lee CH
    Bioorg Med Chem; 2008 Sep; 16(18):8516-25. PubMed ID: 18722778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy.
    Facer P; Casula MA; Smith GD; Benham CD; Chessell IP; Bountra C; Sinisi M; Birch R; Anand P
    BMC Neurol; 2007 May; 7():11. PubMed ID: 17521436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord.
    Bianchi BR; El Kouhen R; Chen J; Puttfarcken PS
    Eur J Pharmacol; 2010 May; 633(1-3):15-23. PubMed ID: 20153316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profiling of the TRPV3 channel in recombinant and native assays.
    Grubisha O; Mogg AJ; Sorge JL; Ball LJ; Sanger H; Ruble CL; Folly EA; Ursu D; Broad LM
    Br J Pharmacol; 2014 May; 171(10):2631-44. PubMed ID: 23848361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Activation of Thermo-Transient Receptor Potential Vanilloid 3 Channels Inhibits Hair Growth by Inducing Cell Death of Hair Follicle Outer Root Sheath.
    Yan K; Sun X; Wang G; Liu Y; Wang K
    J Pharmacol Exp Ther; 2019 Aug; 370(2):299-307. PubMed ID: 31152005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide (JTS-653), a novel transient receptor potential vanilloid 1 antagonist.
    Kitagawa Y; Miyai A; Usui K; Hamada Y; Deai K; Wada M; Koga Y; Sakata M; Hayashi M; Tominaga M; Matsushita M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):520-8. PubMed ID: 22588258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPV3.
    Yang P; Zhu MX
    Handb Exp Pharmacol; 2014; 222():273-91. PubMed ID: 24756710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of novel (6-aminopyridin-3-yl)(4-(pyridin-2-yl)piperazin-1-yl) methanone derivatives as TRPV4 antagonists for the treatment of pain.
    Tsuno N; Yukimasa A; Yoshida O; Suzuki S; Nakai H; Ogawa T; Fujiu M; Takaya K; Nozu A; Yamaguchi H; Matsuda H; Funaki S; Yamanada N; Tanimura M; Nagamatsu D; Asaki T; Horita N; Yamamoto M; Hinata M; Soga M; Imai M; Morioka Y; Kanemasa T; Sakaguchi G; Iso Y
    Bioorg Med Chem; 2017 Apr; 25(7):2177-2190. PubMed ID: 28284871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol sensitises the transient receptor potential channel TRPV3 to lower temperatures and activator concentrations.
    Klein AS; Tannert A; Schaefer M
    Cell Calcium; 2014 Jan; 55(1):59-68. PubMed ID: 24406294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels.
    Spyra S; Meisner A; Schaefer M; Hill K
    Br J Pharmacol; 2017 Aug; 174(16):2696-2705. PubMed ID: 28567799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
    Blum CA; Caldwell T; Zheng X; Bakthavatchalam R; Capitosti S; Brielmann H; De Lombaert S; Kershaw MT; Matson D; Krause JE; Cortright D; Crandall M; Martin WJ; Murphy BA; Boyce S; Jones AB; Mason G; Rycroft W; Perrett H; Conley R; Burnaby-Davies N; Chenard BL; Hodgetts KJ
    J Med Chem; 2010 Apr; 53(8):3330-48. PubMed ID: 20307063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
    Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium plays a central role in the sensitization of TRPV3 channel to repetitive stimulations.
    Xiao R; Tang J; Wang C; Colton CK; Tian J; Zhu MX
    J Biol Chem; 2008 Mar; 283(10):6162-74. PubMed ID: 18178557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacy.
    Voight EA; Gomtsyan AR; Daanen JF; Perner RJ; Schmidt RG; Bayburt EK; DiDomenico S; McDonald HA; Puttfarcken PS; Chen J; Neelands TR; Bianchi BR; Han P; Reilly RM; Franklin PH; Segreti JA; Nelson RA; Su Z; King AJ; Polakowski JS; Baker SJ; Gauvin DM; Lewis LR; Mikusa JP; Joshi SK; Faltynek CR; Kym PR; Kort ME
    J Med Chem; 2014 Sep; 57(17):7412-24. PubMed ID: 25100568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.